Business Description
Mercury Biopharmaceutical Corp
ISIN : TW0006932007
Description
Mercury Biopharmaceutical Corp focuses on the development of drugs for unmet medical needs. It offers a development platform focusing on rapid release and free adjustable doses. Its 3D powder bonding method (binder jetting) combines powder and special molding adhesive and stacks them in layers.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.77 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -1.09 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 67.71 | |||||
| Beneish M-Score | -3.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -262.2 | |||||
| 3-Year EPS without NRI Growth Rate | -280.3 | |||||
| 3-Year FCF Growth Rate | -308.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.51 | |||||
| 9-Day RSI | 13.06 | |||||
| 14-Day RSI | 18.55 | |||||
| 6-1 Month Momentum % | -21.2 | |||||
| 12-1 Month Momentum % | -29.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 42.21 | |||||
| Quick Ratio | 42.21 | |||||
| Cash Ratio | 40.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -58.4 | |||||
| Shareholder Yield % | -4.85 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.31 | |||||
| Operating Margin % | -4423.04 | |||||
| Net Margin % | -4241.63 | |||||
| FCF Margin % | -5393.61 | |||||
| ROE % | -13.4 | |||||
| ROA % | -11.66 | |||||
| ROIC % | -47.68 | |||||
| ROC (Joel Greenblatt) % | -53.4 | |||||
| ROCE % | -11.68 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3850.01 | |||||
| PB Ratio | 12.37 | |||||
| Price-to-Tangible-Book | 12.42 | |||||
| EV-to-EBIT | -104.81 | |||||
| EV-to-EBITDA | -115.74 | |||||
| EV-to-Revenue | 4373.32 | |||||
| EV-to-FCF | -94.89 | |||||
| Price-to-Net-Current-Asset-Value | 16.5 | |||||
| Price-to-Net-Cash | 17.24 | |||||
| Earnings Yield (Greenblatt) % | -0.96 | |||||
| FCF Yield % | -1.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mercury Biopharmaceutical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1.033 | ||
| EPS (TTM) (NT$) | -0.11 | ||
| Beta | 0 | ||
| Volatility % | 29.59 | ||
| 14-Day RSI | 18.55 | ||
| 14-Day ATR (NT$) | 0.844814 | ||
| 20-Day SMA (NT$) | 14.32 | ||
| 12-1 Month Momentum % | -29.62 | ||
| 52-Week Range (NT$) | 11.35 - 27.35 | ||
| Shares Outstanding (Mil) | 415.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mercury Biopharmaceutical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mercury Biopharmaceutical Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mercury Biopharmaceutical Corp Frequently Asked Questions
What is Mercury Biopharmaceutical Corp(ROCO:6932)'s stock price today?
The current price of ROCO:6932 is NT$11.55. The 52 week high of ROCO:6932 is NT$27.35 and 52 week low is NT$11.35.
When is next earnings date of Mercury Biopharmaceutical Corp(ROCO:6932)?
The next earnings date of Mercury Biopharmaceutical Corp(ROCO:6932) is .
Does Mercury Biopharmaceutical Corp(ROCO:6932) pay dividends? If so, how much?
Mercury Biopharmaceutical Corp(ROCO:6932) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers